Validation and application of reporter gene assays for the determination of estrogenic and androgenic endocrine disruptor activity in sport supplements

Abstract

Previously developed estrogen and androgen mammalian reporter gene assays (RGAs) were assessed for their potential use as a quantitative screening method in the detection of estrogenic and androgenic endocrine disruptors (EDs) in sport supplements. The validation of both RGAs coupled with dispersive solid phase extraction (dSPE) was performed in accordance with European Commission Decision EC/2002/6579 for biological screening methods. Decision limits (CCα) and detection capabilities (CCβ) were established for both the estrogen and androgen RGAs. All samples were compliant with CCα and CCβ in both bioassays. Recovery rates were 96 % for 17β-estradiol and 115 % for dihydrotestosterone as obtained in their corresponding RGA. Both estrogens and androgens were stable in samples for more than 3 weeks, when stored at -20 °C. Specificity, good repeatability (coefficients of variation (CV), 12-25 %), reproducibility and robustness of both bioassays were also observed. Four different ED modes of action were determined for estrogens and androgens in 53 sport supplements, using the validated RGAs. This study revealed that 89 % of the investigated sport supplements contained estrogenic EDs and 51 % contained androgenic compounds. In conclusion, both bioassays are suitable for sport supplement screening of estrogenic and androgenic EDs.

Endocrine disruptor activity of multiple environmental food chain contaminants

“…Other explanations such as progesterone-like activity of PBBu or highly estrogenic metabolite formation also have to be taken into consideration. However, since the employed cell line was deemed estrogen specific (Plotan et al, 2012;Wielogorska et al, 2014) the former assumption was rejected as a possible cause of such a high response. Also, -Bu and -Pr, both enhanced the E2 response almost seven times (Fig.…”

Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review

“…The use of bioassays, such as the estrogen and androgen mammalian reporter gene assays (RGAs) and the yeast androgen bioassay, have been suggested as a general screening procedure to detect steroids in sports dietary supplements (Rijk and others ; Plotan and others ). These bioassays present several advantages, such as high sensitivity and lower cost, compared to methods that require the use of advanced and expensive equipment, as well as high throughput as they screen samples for a large group of compounds presenting similar biological effects.…”

A 155-plex high-throughput in vitro coregulator binding assay for (anti-)estrogenicity testing evaluated with 23 reference compounds

“…Unlike receptor binding assays, reporter gene assays can distinguish between agonist and antagonist activity. Several reporter gene assays have been developed and applied as screening tools to determine the estrogenic/ anti-estrogenic activities of compounds, as they are cheap, fast, robust, and have been shown to produce relevant and reliable outcomes van der Burg et al, 2010;Plotan et al, 2012). Proliferation assays and low-density DNA microchipbased analysis of marker gene expression also have been shown to provide valuable tools for estrogenicity testing, and outcomes correlate well with the in vivo uterotrophic assay (Wang et al, 2012(Wang et al, , 2013, but these two assays are laborious and require 3-6 days.…”